Variable Manifestations of Familial Hemiplegic Migraine Associated With Reversible Cerebral Edema in Children

Section of Pediatric Neurology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.
Pediatric Neurology (Impact Factor: 1.5). 09/2012; 47(3):201-4. DOI: 10.1016/j.pediatrneurol.2012.05.006
Source: PubMed

ABSTRACT Three children with familial hemiplegic migraine presented with right-sided weakness, speech difficulty, altered mental status, and gait abnormalities. These persistent aura signs were accompanied by left-sided slowing and cerebral dysfunction, documented by electroencephalograms. Cranial magnetic resonance imaging revealed cortical edema restricted to the left cerebral hemisphere. Follow-up electroencephalogram and imaging studies produced normal results 1-4 months afterward. However, cognitive changes persisted. Genetic testing demonstrated variable results: one child manifested a CACNA1A mutation compatible with familial hemiplegic migraine type 1, whereas another demonstrated an ATP1A2 sequence alteration. No known mutations were evident in the third child, with minor head trauma thought to precipitate the familial hemiplegic migraine. These findings demonstrate the variable clinical and genetic heterogeneity of childhood familial hemiplegic migraine.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Sporadic and familial hemiplegic migraines are rare paroxysmal disorders characterized by transient hemiparesis and headache. The distinction is based on whether other family members are affected. In 50% of cases, these migraines are caused by CACNA1 A missense mutations. We describe a patient with a particularly severe phenotype and a de novo R1349Q mutation on the CACNA1 A gene. The patient suffered from early-onset profound mental retardation, epileptic seizures, cerebellar ataxia, and progressive cerebellar atrophy. He experienced prolonged attacks of migraine with hemiparesis, seizures, altered consciousness, and fever resulting from minor head traumas. A prolonged hemiplegic attack improved following a 5-day treatment of 100 mg/d methylprednisolone. R1349Q mutation of the CACN1 A gene is associated with a severe phenotype. Corticoids might be beneficial in prolonged hemiplegic attacks.
    Pediatric Neurology 07/2013; DOI:10.1016/j.pediatrneurol.2013.04.011 · 1.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hoofdpijn bij kinderen is een veelvoorkomend probleem. Op de kinderleeftijd zijn er veel verschillende primaire hoofdpijnvormen, waarvan de meest voorkomende, migraine en spanningshoofdpijn, qua kenmerken niet wezenlijk verschillen van de hoofdpijn bij volwassenen. Op de kinderleeftijd komt een aantal leeftijdsgebonden specifieke migrainetypen voor en specifieke leeftijdsgebonden syndromen die niet direct geassocieerd worden met migraine. De behandeling van de diverse vormen van primaire hoofdpijn kan bestaan uit een medicamenteuze en een niet-medicamenteuze therapie. Alvorens deze behandeling te starten, moet aandacht worden besteed aan leefstijl en voeding, en wordt de mogelijkheid van medicatieovergebruik overwogen. De medicamenteuze behandeling verschilt niet wezenlijk van de therapie bij volwassenen, met uitzondering van het gebruik van triptanen vanaf de leeftijd van 12 jaar.
    02/2013; 29(1). DOI:10.1007/s12414-013-0009-z
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: ATP1A3 mutations have now been recognized in infants and children presenting with a diverse group of neurological phenotypes, including Rapid-onset Dystonia-Parkinsonism (RDP), Alternating Hemiplegia of Childhood (AHC), and most recently, Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy, and Sensorineural hearing loss (CAPOS) syndrome. Existing literature on ATP1A3-related disorders in the pediatric population were reviewed, with attention to clinical features and associated genotypes among those with RDP, AHC, or CAPOS syndrome phenotypes. While classically defined phenotypes associated with AHC, RDP, and CAPOS syndromes are distinct, common elements among ATP1A3-related neurological disorders include characteristic episodic neurological symptoms and signs that vary in severity, duration, and frequency of occurrence. Affected children typically present in the context of an acute onset of paroxysmal, episodic neurological symptoms ranging from oculomotor abnormalities, hypotonia, paralysis, dystonia, ataxia, seizure-like episodes, or encephalopathy. Neurodevelopmental delays or persistence of dystonia, chorea, or ataxia after resolution of an initial episode are common, providing important clues for diagnosis. The phenotypic spectrum of ATP1A3-related neurological disorders continues to expand beyond the distinct yet overlapping phenotypes in patients with AHC, RDP, and CAPOS syndromes. ATP1A3 mutation analysis is appropriate to consider in the diagnostic algorithm for any child presenting with episodic or fluctuating ataxia, weakness or dystonia whether they manifest persistence of neurological symptoms between episodes. Additional work is needed to better identify and classify affected patients and develop targeted treatment approaches. Copyright © 2014 Elsevier Inc. All rights reserved.
    Pediatric Neurology 10/2014; 52(1). DOI:10.1016/j.pediatrneurol.2014.09.015 · 1.50 Impact Factor